Status
Conditions
Treatments
About
The aim of this study was to evaluate whether C4d is a better biomarker and examine whether C4d plasma levels correlate with treatment response and C4d kidney deposition in systemic lupus erythematosus (SLE) with lupus nephritis (LN).
Full description
Evaluation of C4d in lupus nephritis in children C4d level difference in children with systemic lupus with and without renal affection C4d level in lupus nephritis at activity and after remission Detection of C4d deposition in renal tissue relation to disease activity
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
This will include children and adolescents who fulfill the 2012 Systemic Lupus International Collaborating Clinics (SLICC)(10) classification criteria of SLE.
Inclusion Criteria:
Exclusion criteria
30 participants in 2 patient groups
Loading...
Central trial contact
Aya Khalifa, assisstant lecterurer; Ahalam Ali, assisstant professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal